Log in
Enquire now
‌

US Patent 10494634 Factor XIa-specific aptamers

Patent 10494634 was granted and assigned to Canadian Blood Services on December, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Canadian Blood Services
Canadian Blood Services
0
Current Assignee
Canadian Blood Services
Canadian Blood Services
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
104946340
Patent Inventor Names
William Peter Sheffield0
David Apraku Donkor0
Date of Patent
December 3, 2019
0
Patent Application Number
155865810
Date Filed
May 4, 2017
0
Patent Citations Received
‌
US Patent 11649460 DNA aptamers, method for inhibiting human galectin-1 and method of treating a mammal in need thereof
0
Patent Primary Examiner
‌
Kimberly Chong
0
Patent abstract

The present disclosure concerns aptamers of formula (I) capable of specifically binding to Factor XIa. The aptamers can be used to prevent, treat or alleviate the symptoms of thrombosis. The aptamers can also be used to detect Factor XIa in a sample and/or purify Factor XIa from a sample. The aptamers can further be used to identity putative therapeutic agents for the prevention, treatment or alleviation of symptoms associated with thrombosis.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10494634 Factor XIa-specific aptamers

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.